Full text is available at the source.
Abstract
Delivery of mRNA encoding the ovalbumin epitope SIINFEKL led to expansion of ovalbumin-specific OT1 CD8+ T cells to up to 80% of all circulating CD8+ T cells.
- Adoptive T cell therapy has limited effectiveness against solid tumors like brain tumors due to challenges in accessing target antigens.
- Using an mRNA vaccine to encode the target antigen can enhance the restimulation and persistence of transferred TCR-T cells.
- RNA vaccination significantly improved T cell infiltration in the brain and maintained an active immune response, which suppressed glioblastoma growth.
- In an experimental model, co-administration of dendritic cells with PTPRZ1-mRNA resulted in successful rejection of human gliomas expressing the target antigen.
- These results indicate that mRNA vaccines may effectively enhance TCR-T cell therapy for glioblastoma.
Simplified